Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Mélody Caillot"'
Autor:
Manon Durand, Vincent Cabaud Gibouin, Laurence Duplomb, Leila Salmi, Mélody Caillot, Brigitte Sola, Vincent Camus, Fabrice Jardin, Carmen Garrido, Gaëtan Jego
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-16 (2024)
Abstract Background Primary mediastinal B-cell lymphoma (PMBL) and classical Hodgkin lymphoma (cHL) are distinct hematological malignancies of B-cell origin that share many biological, molecular, and clinical characteristics. In particular, the JAK/S
Externí odkaz:
https://doaj.org/article/abefe082f2a242b38b5c9e12bfa576a1
Autor:
Mélody Caillot, Hadjer Miloudi, Antoine Taly, Nuria Profitós‐Pelejà, Juliana C. Santos, Marcelo L. Ribeiro, Elsa Maitre, Simon Saule, Gaël Roué, Fabrice Jardin, Brigitte Sola
Publikováno v:
Molecular Oncology, Vol 17, Iss 12, Pp 2546-2564 (2023)
Exportin 1 (XPO1) is the main nuclear export receptor that controls the subcellular trafficking and the functions of major regulatory proteins. XPO1 is overexpressed in various cancers and small inhibitors of nuclear export (SINEs) have been develope
Externí odkaz:
https://doaj.org/article/15e5148ed1e04b5480ee7573912d7a4b
Autor:
Mélody Caillot, Florence Zylbersztejn, Elsa Maitre, Jérôme Bourgeais, Olivier Hérault, Brigitte Sola
Publikováno v:
Cells, Vol 9, Iss 11, p 2357 (2020)
Multiple myeloma (MM) is a plasma cell neoplasm that remains incurable due to innate or acquired resistance. Although MM cells produce high intracellular levels of reactive oxygen species (ROS), we hypothesised that they could remain sensitive to ROS
Externí odkaz:
https://doaj.org/article/221cd305d9324ae48892552df5b3774d
Autor:
Brigitte Sola, Mélody Caillot
Publikováno v:
médecine/sciences. 38:795-799
Le développement de drogues anti-cancéreuses à visée thérapeutique nécessite leur évaluation. Ces drogues candidates sont généralement testées in vitro, sur des lignées cellulaires ou sur des cellules isolées à partir de patients, et, in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b49b073cdb5e5550fcd450597401ce6a
https://doi.org/10.1051/medsci/2022123
https://doi.org/10.1051/medsci/2022123
Autor:
null Mélody Caillot, null Hadjer Miloudi, null Antoine Taly, null Nuria Profitós‐Pelejà, null Juliana C. Santos, null Marcelo L. Ribeiro, null Elsa Maitre, null Simon Saule, null Gaël Roué, null Fabrice Jardin, null Brigitte Sola
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e68ebb999e701354a423e042a8ac9aa
https://doi.org/10.1002/1878-0261.13386/v2/response1
https://doi.org/10.1002/1878-0261.13386/v2/response1
Autor:
Brigitte, Sola, Mélody, Caillot
Publikováno v:
Medecine sciences : M/S. 38(10)
For therapeutic purposes, the development of new anti-cancer drugs requires their evaluation in terms of activity, cytotoxicity and pharmacokinetics. The candidate drugs are tested in vitro on cell lines and primary cells isolated from patients, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7197c9b3a0615463ebbde99ce033bae8
https://pubmed.ncbi.nlm.nih.gov/36219079
https://pubmed.ncbi.nlm.nih.gov/36219079
Autor:
Mélody Caillot, Hadjer Miloudi, Antoine Taly, Elsa Maitre, Simon Saule, Fabrice Jardin, Brigitte Sola
Exportin 1 (XPO1) is the main nuclear export receptor that controls the subcellular trafficking and the functions of major regulatory proteins. XPO1 is overexpressed in various cancers and small inhibitors of nuclear export (SINEs) have been develope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8830862c5e9330ef4ff19d6b87ee91bd
https://doi.org/10.1101/2022.07.19.500622
https://doi.org/10.1101/2022.07.19.500622
Autor:
Ahlem Chahbi, Mohamed Abdelkarim, Emna Berred, Mélody Caillot, Brigitte Sola, Fatma Ben Aissa-Fennira, Oumaima Jaouadi, Inès Limam
Publikováno v:
Cancers
Cancers, MDPI, 2021, 13 (15), pp.3747. ⟨10.3390/cancers13153747⟩
Volume 13
Issue 15
Cancers, Vol 13, Iss 3747, p 3747 (2021)
Cancers, MDPI, 2021, 13 (15), pp.3747. ⟨10.3390/cancers13153747⟩
Volume 13
Issue 15
Cancers, Vol 13, Iss 3747, p 3747 (2021)
Multiple myeloma (MM) is an incurable plasma cell malignancy with frequent patient relapse due to innate or acquired drug resistance. Cholesterol metabolism is reported to be altered in MM
therefore, we investigated the potential anti-myeloma ac
therefore, we investigated the potential anti-myeloma ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a08b49d10258cb620f2ecdb207d61836
https://hal-normandie-univ.archives-ouvertes.fr/hal-03358345/file/cancers-13-03747.pdf
https://hal-normandie-univ.archives-ouvertes.fr/hal-03358345/file/cancers-13-03747.pdf
Publikováno v:
Cancers
Cancers, MDPI, 2021, 13 (10), pp.2411. ⟨10.3390/cancers13102411⟩
Cancers, Vol 13, Iss 2411, p 2411 (2021)
Cancers, MDPI, 2021, 13 (10), pp.2411. ⟨10.3390/cancers13102411⟩
Cancers, Vol 13, Iss 2411, p 2411 (2021)
Simple Summary Multiple myeloma (MM) is a neoplastic disease of plasma cells, characterized by a complex array of clinical manifestations. Despite extensive efforts and progress in the care of MM patients, the disease is still fatal because of de nov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91c43d8abd57110975058a5867a099fa
https://pubmed.ncbi.nlm.nih.gov/34067602
https://pubmed.ncbi.nlm.nih.gov/34067602
Autor:
Hassan Dakik, Jérôme Bourgeais, Brigitte Sola, É. Costé, Frédéric Mazurier, O. Coqueret, Mélody Caillot, Olivier Herault, É. Lelièvre, Nathalie M. Mazure
Publikováno v:
Oncogenesis
Oncogenesis, Nature Publishing Group: Open Access Journals-Option C, 2020, 9 (7), ⟨10.1038/s41389-020-00253-3⟩
Oncogenesis, Vol 9, Iss 7, Pp 1-13 (2020)
Oncogenesis, 2020, 9 (7), pp.68. ⟨10.1038/s41389-020-00253-3⟩
Oncogenesis, Nature Publishing Group: Open Access Journals-Option C, 2020, 9 (7), pp.68. ⟨10.1038/s41389-020-00253-3⟩
Oncogenesis, Nature Publishing Group: Open Access Journals-Option C, 2020, 9 (7), ⟨10.1038/s41389-020-00253-3⟩
Oncogenesis, Vol 9, Iss 7, Pp 1-13 (2020)
Oncogenesis, 2020, 9 (7), pp.68. ⟨10.1038/s41389-020-00253-3⟩
Oncogenesis, Nature Publishing Group: Open Access Journals-Option C, 2020, 9 (7), pp.68. ⟨10.1038/s41389-020-00253-3⟩
Cancer cells are characterized by the Warburg effect, a shift from mitochondrial respiration to oxidative glycolysis. We report here the crucial role of cyclin D1 in promoting this effect in a cyclin-dependent kinase (CDK)4/6-independent manner in mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c3c17da62bae0baa6bf45c6dbc03e79
https://hal.archives-ouvertes.fr/hal-03429091
https://hal.archives-ouvertes.fr/hal-03429091